Yellow fever other feverish illnesses such as malaria. Other viral hemorrhagic fevers, such as Ebola virus, Lassa virus, Marburg virus, and Junin virus, must be excluded as the cause. Personal prevention of yellow fever includes vaccination and avoidance of mosquito bites in areas where yellow fever is endemic. Institutional measures for prevention of yellow fever include vaccination programmes and measures of controlling mosquitoes. Programmes for distribution of mosquito nets for use in homes are providing reductions in cases of both malaria and yellow fever. Use of EPA-registered insect repellent is recommended when outdoors. Exposure for even a short time is enough for
Rabbit haemorrhagic disease myxomatosis. FILAVAC has been authorised by the VMD in April 2017 ; it is currently the only vaccine containing both classic and variant strain of VHD virus. New outbreak in Canada reported on Vancouver Island http://www.cbc.ca/news/canada/british-columbia/b-c-issues-warning-to-pet-rabbit-owners-as-virus-spreads-to-lower-mainland-1.4587233 Rabbit haemorrhagic disease Rabbit haemorrhagic disease (RHD), also known as rabbit calicivirus disease (RCD) or viral haemorrhagic disease (VHD), is a highly infectious and often fatal disease that affects wild and domestic rabbits of the species "Oryctolagus cuniculus". The infectious agent responsible for the disease is rabbit haemorrhagic disease virus (RHDV), or rabbit calicivirus (RCV), genus "Lagovirus" of the family Caliciviridae. The virus infects